Carcinoma, NeuroendocrineФаза 2NCT06406465
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Belinostat, Cisplatin, Etoposide
16 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Thyroid and neuroendocrine16 studies
Carcinoma, NeuroendocrineФаза 2NCT06406465
Belinostat, Cisplatin, Etoposide
Advanced Pheochromocytoma and ParagangliomaФаза 2NCT07282587
ONC206, ONC206: Dose 1, ONC206: Dose 2
PheochromocytomaФаза 2NCT03206060Papers
Lu-177-DOTATATE, Ga-68-DOTATATE
Pheochromocytoma/ParagangliomaФаза 2NCT04924075Papers
Belzutifan
Inoperable Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET)Phase 1/2NCT04086485Papers
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Thyroid CancerФаза 2NCT06007924
Avutometinib, Defactinib
High Grade Neuroendocrine NeoplasmsФаза 2NCT06926634
Zanzalintinib
Neuroendocrine Tumor Grade 2Фаза 2NCT04339036Papers
Capecitabine Oral Product, Temozolomide Oral Product, transarterial radioembolization
BRAF V600E Wild-Type Anaplastic Thyroid CancerPhase 1NCT06902376
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
Locally Advanced Adrenal Cortical CarcinomaФаза 2NCT06900595
Biospecimen Collection, Cabozantinib, Cemiplimab, Computed Tomography
Neoadjuvant TreatmentФаза 2NCT06959511
Zanzalintinib
Metastatic Thyroid CancerФаза 2NCT03099356
Cyclophosphamide, Sirolimus
Differentiated Thyroid CancerФаза 2NCT06458036
Selpercatinib Monotherapy, 131I Therapy
Recurrent Differentiated Thyroid CancerPhase 1NCT04892303
Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer
Locally Advanced Differentiated Thyroid Gland CarcinomaФаза 2NCT06959641
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Survey Administration
Neuroendocrine CarcinomaPhase 1NCT06889493
SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)